• Contact Info
  • +61 3 9479 2158
  • Websites

Professor Michael Foley Professor, Biochemistry

Mick completed his BSc in Microbiology at Glasgow College of Technology in 1982 and embarked on a PhD in biophysics of parasitic helminths with Prof. Peter Garland in the Department of Biochemistry, University of Dundee. Upon completion of his PhD he was awarded a Wellcome Training Fellowship and worked with Dr Robin Anders in the Immunoparasitology group at the Walter and Elisa Hall Institute on malaria, particularly the molecular biology of the host parasite interface. After a couple of years as a Wellcome Research Fellow in David Wallikers group at the University of Edinburgh, Mick returned to the Department of Biochemistry at La Trobe University where he worked with Leann Tilley on the mechanism of action of anti-malarial drugs. During his time in Edinburgh he carried out a field trip to the Sudan and later in 1994 he visited Mongolia as an International Atomic Energy Agency (IAEA) expert scientist. In 1995 he was awarded an ARC QEII Fellowship where he established the phage display of antibodies and peptide technology as a means of unlocking the secrets of the invasion of malaria parasites into red blood cells.

Since establishing his laboratory at La Trobe University in 1994, Mick has carried out both basic academic research and translational research. He has been involved in three CRCs; leading projects in the CRC for Diagnostics and the CRC for Biomarker translation. He has received funding support from Philanthropic, Government and the Pharma/Biotech Industry such as NHMRC, ARC, WHO and the National Institutes for Health (USA) and the Malaria Vaccine Initiative and USAID as well as almost 18 years continuous funding by the CRC scheme. In 2007, Mick became founding scientist and Chief Scientific Officer of AdAlta, a spin off company of the CRC for diagnostics. AdAlta is currently commercializing the single domain antibodies particularly against GPCR and ion channel targets in fibrosis and other chronic diseases. He is an inventor on three patents. He has received support for his research from National Health and Medical Research, Australian Research Council, World Health Organisation and the National Institutes of Health (USA) and has been funded since 1994 by the CRC scheme. Recently the lab has had funding from the Malaria Vaccine Initiative and USAID. Currently he is Chief Scientific Officer for AdAlta Pty.Ltd. Mick was born in Scotland. His interests are Golf (where he sometimes lets Robin Anders win), and Glasgow Celtic - the greatest football team the Universe has ever seen.


Research Areas research areas